Stock ABEO ABEONA THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Market Closed - Nasdaq
Other stock markets
 01:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
4.22 USD -2.99% Intraday chart for Abeona Therapeutics Inc. -7.05% -15.77%
18/06 Abeona Therapeutics Files for $300 Million Mixed Shelf, $75 Million At-The-Market Offering MT
30/05 Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target MT

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Abeona Therapeutics Inc. Appoints Madhav Vasanthavada as Chief Commercial Officer
CI
Abeona Therapeutics Inc. Announces Management Changes
CI
Abeona Therapeutics Inc. Appoints Jon Voss as Vice President, Head of Quality
CI
Precision BioSciences : Names Michael Amoroso President, Chief Executive
MT
Abeona Therapeutics Inc. Announces Board and Management Changes
CI
Abeona Therapeutics : Names CEO, Chairman
MT
Abeona Therapeutics Inc. Appoints Dr. Vishwas Seshadri as Chief Executive Officer, Effective October 15, 2021
CI
Abeona Therapeutics Inc. Appoints Edward Carr as Senior Vice President
CI
Abeona Therapeutics Inc. Appoints Edward Carr as Principal Financial Officer
CI
Abeona Therapeutics Appoints Edward Carr as Chief Financial Officer
CI
Abeona Therapeutics Inc. Announces Board Committee Appointments
CI
Abeona Therapeutics Inc. Appoints Vishwas Seshadri as Senior Vice President, Head of Research & Clinical Development
CI
Abeona Therapeutics Inc. Announces Appointment of Michael Amoroso as President and a Member of the Company's Board of Directors
CI
Abeona Therapeutics Inc. Announces Board Appointments
CI
Abeona Therapeutics Inc. Appoints Faith Charles and Mark Alvino as Independent Members to Board of Directors
CI
Abeona Therapeutics Inc. Promotes Michael Amoroso to President and A Member of Board of Directors
CI
Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Executive Officer
CI
Abeona Therapeutics Inc. Announces the Appointment of Michael Amoroso as Chief Operating Officer, with effect from November 01, 2020
CI
Abeona Therapeutics Inc. Announces Board Changes
CI
Abeona Therapeutics Inc. Announces Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABEO Stock
  4. News Abeona Therapeutics Inc.
  5. Insiders